One of the most frustrating questions women ask during perimenopause is:

“Is this symptom hormonal… or is something else going on?”

Because during this transition:

But these same symptoms can ALSO be caused by:

So determining what’s hormonal and what’s lifestyle has been nearly impossible — until now.

In late 2025, Withings and Clue announced a major partnership that directly tackles this problem. It merges:

Continuous temperature, HR, HRV, sleep depth, breathing, and stress patterns.

Perimenopause tracking, cycle changes, mood patterns, vasomotor symptoms, triggers.

Together, they create a system that finally helps women understand:

“This is your hormones speaking”
vs.
“This is just life happening.”

For women navigating perimenopause — the most important decade for bone density — that clarity is priceless.

Every wearable is great at collecting biometric data.
But most wearables are not great at interpreting that data through the lens of:

Without interpretation, data is just chaos.

Women look at their wearables and ask:

These questions matter — not just for comfort, but for:

The Withings × Clue integration brings meaning to the chaos.

The ScanWatch 2 continuously measures:

Clue logs:

The platforms combine datasets and look for patterns, such as:

Before the integration
Women see:
“Woke up at 2:13am. HR spike + temperature rise.”

After the integration
Clue reveals:
“You logged a hot flash at the same time your temperature rose 0.7°, suggesting this wake-up is vasomotor, not stress-related.”

This matters because women often blame themselves:

“Why can’t I sleep? What am I doing wrong?”

Instead, they now see:

“No, this was physiological — not my fault.”

Before
HRV crashes for a week and women assume they’re:

After
Clue can show:
“Your HRV drops consistently occur during the late luteal phase — this is hormonally expected.”

Meaning:

Nothing is “wrong.”
Your body is shifting.

Before
Cycle goes from 27 days → 36 days.
Panic, confusion, annoyance, Google searches.

After
Clue + Withings can detect associated changes:

Instead of guessing:
You see the physiological “why” behind the shift.

Before
One glass of wine leads to terrible sleep.
Women blame hormones.
Women blame themselves.
Women feel overwhelmed.

After
Withings/Clue can show:

And alongside this:

Meaning:

“It wasn’t hormones today — this was alcohol-driven sleep disruption.”

That distinction gives women power — not confusion.

Perimenopause is ground zero for accelerated bone loss.
The body becomes more sensitive to:

Women navigating OsteoStrong’s bone-building program or a strength-training routine often notice:

Without hormonal context, these “off days” feel like:

“I’m failing.”
“I’m losing progress.”
“I’m getting weaker.”

But when Withings + Clue reveal:

(matches mid-perimenopause)

(mimics overtraining physiology)

(reduces recovery capacity)

(affects energy & stability)

Suddenly the narrative shifts:

“This is a pattern — not a failure.”

ILM Aesthetics & Wellness has been helping women navigate hormones, functional health, and perimenopause-related challenges for years.

At OsteoStrong, we see:

We don’t treat hormones.
We don’t diagnose hormonal phases.
We don’t manage hormone therapy.

But we do support:

And women navigating perimenopause often see their best results when they understand what their body is doing physiologically, not just symptomatically.

The Withings × Clue integration is a powerful complement to that.

To remain accurate and ethical:

The Withings × Clue integration does NOT:

It is a pattern-recognition tool, not a medical tool.

But that pattern recognition is exactly what women have been missing.

Peri = detects hot flashes & autonomic patterns.
Natural Cycles NC° Perimenopause = interprets hormonal timeline.
Withings × Clue = identifies what’s hormonal vs lifestyle.

Together, they represent a new era where:

For the first time ever, women aren’t told:

“Just wait it out.”

Instead, they’re given:

A long-overdue shift.

Because perimenopause is not a “mystery stage.”
It’s a physiological transition with measurable patterns.

And women deserve:

Withings and Clue are helping create that — and the impact on daily life, sleep, bone health, stress, and longevity could be enormous.

This concludes our 3-part perimenopause tech series — but it’s only the beginning of a larger movement toward giving women data, not dismissal.

1. Withings Official Press Release (Media Center PDF)
“Withings and Clue Partner to Empower Women With Smarter Health and Cycle Tracking” (Sept 22, 2025)

2. Wellworthy.com Reporting
Summary of the Withings × Clue partnership and benefits.

3. El País (Cinco Días)
Coverage of new ScanWatch updates and female-focused features.

4. Clue Health App Documentation
Symptom tracking + perimenopause module overview.

5. WHO / NAMS Data
Research on sleep, vasomotor symptoms, and stress load in perimenopause.

Across America, communities are being powered thanks to investors on Climatize who have committed to a brighter future.

Climatize lists vetted renewable energy investment offerings in different states.

As of November 2025, over $13.2 million has been invested across 28 projects on the platform, and over $3.6 million has already been returned to our growing community of thousands of members. Returns aren’t guaranteed, and past performance does not predict future results.

On Climatize, you can explore vetted clean energy offerings, including past projects like solar farms in Tennessee, grid-scale battery storage units in New York, and EV chargers in California. Each offering is reviewed for transparency and provides a clear view of how clean energy takes shape.

Investors can access clean energy projects from $10 through Climatize. Through Climatize, you can see and hear about the end impact of your money in our POWERED by Climatize stories.

Explore Energy Projects with code BEEH1V

_{Climatize is an SEC-registered & FINRA member funding portal. Crowdfunding carries risk, including loss.}